Evidence map›Paper›PMID 32574191›Full record

ArticlePloS one2020

Antifibrotic role of low-dose mitomycin-c-induced cellular senescence in trabeculectomy models.

Le-Tien Lin, Jiann-Torng Chen, Da-Wen Lu, Ming-Cheng Tai, Chang-Min Liang, Ching-Long Chen, Shu-I Pao, Chih-Kang Hsu, Yi-Hao Chen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Galectin-3 Mediates TGF-β-Controlled Migration in Müller Glial Cells.International journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Le-Tien LinDepartment of Ophthalmology, Tri-Service General Hospital Songshan Branch, National Defense Medical Center, Taipei, Taiwan, Republic of China.ORCID 0000-0003-0105-4206
Jiann-Torng ChenGraduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Da-Wen LuGraduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Ming-Cheng TaiGraduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Chang-Min LiangGraduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Ching-Long ChenGraduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Shu-I PaoDepartment of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Chih-Kang HsuDepartment of Ophthalmology, Tri-Service General Hospital Songshan Branch, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Yi-Hao ChenGraduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China.ORCID 0000-0002-9977-7180
Tri-Service General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe assessed whether mitomycin-C (MMC) has different antifibrotic mechanisms in trabeculectomy wound healing.

methodsWe identified 2 concentrations of MMC as "low-dose" by using WST-1 assay, Lactic dehydrogenase assay, and fluorescence-activated cell sorting flow cytometry. Senescence-associated β-galactosidase (SA-β-gal) and fibrotic gene expression was examined through immunocytochemistry, flow cytometry, real-time quantitative reverse transcription polymerase chain reaction, Western blotting, zymography, and modified scratch assay in vitro. In vivo, 0.1 mL of MMC or normal saline was injected to Tenon's capsule before trabeculectomy in a rabbit model. SA-β-gal expression, apoptotic cell death, and collagen deposition in sites treated and not treated with MMC were evaluated using terminal dUTP nick end labeling assay and histochemical staining. Bleb function and intraocular pressure (IOP) levels were examined 3, 7, 14, 21, 28, and 35 days after trabeculectomy.

resultsIn vitro, human Tenon's fibroblast (HTF) senescence was confirmed by observing cell morphologic change, SA-β-gal accumulation, formation of senescence-associated heterochromatin, increased p16INK4a and p21CIP1/WAF1 expression, lower percentage of Ki-67-positive cells, and decreased COL1A1 release. Increased expression of α-SMA, COL1A1, and Smad2 signaling in TGF-β1-induced stress fibers were passivated in senescent HTFs. In addition, cellular migration enhanced by TGF-β1was inactivated. In vivo, histological examination indicated increased SA-β-gal accumulation, lower apoptosis ratios, and looser collagen deposition in sites treated with 0.2 μM MMC. Low-dose MMC-induced cellular senescence prolonged trabeculectomy bleb survival and reduced IOP levels in a rabbit model.

conclusionLow-dose MMC-induced cellular senescence is involved in the antifibrotic mechanism of trabeculectomy wound healing.

Indexed as

TrabeculectomyAnimalsBiomarkersCell SurvivalCell TransdifferentiationCellular SenescenceDose-Response Relationship, DrugFibrosisMitomycinMyofibroblastsRabbitsSignal TransductionSmad2 ProteinTransforming Growth Factor beta1Wound HealingBiomarkersMitomycinSmad2 ProteinTransforming Growth Factor beta1

Identifiers

PMID32574191
PMCPMC7310836
OpenAlexW3038040520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.